Malmo
Sweden
8
2026-04-23
3
2026-01-27
These are the the leading inventors for applications assigned to LINNANE PHARMA AB:
LINNANE PHARMA AB based in Malmo, SE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
A COMPLEX COMPRISING A ALPHA-LACTALBUMIN AND A FATTY ACID OR LIPID FOR USE IN THE TREATMENT OR PREVENTION OF CANCER
#2 | 2025-12-25LON PROTEASE, ALPHA-HEMOLYSIN, CK1-ALPHA-1; C-MYB INHIBITOR OR A CEBP-DELTA INHIBITOR AS THERAPEUTICS
#3 | 2024-03-14 ✅ Patent 12,533,393 granted on 2026-01-27VIBRIO CHOLERAE PROTEIN FOR USE AGAINST CANCER
#4 | 2023-11-23METHOD FOR PREPARING A COMPOSITION COMPRISING AN UNFOLDED PROTEIN
#5 | 2023-02-23LON PROTEASE, ALPHA-HEMOLYSIN, CK1-ALPHA-1; C-MYB INHIBITOR OR A CEBP-DELTA INHIBITOR AS THERAPEUTICS
#6 | 2020-08-20 ✅ Patent 11,034,742 granted on 2021-06-15Peptides with antibiotic potential against
#7 | 2020-05-21NOVEL THERAPY
#8 | 2018-04-26 ✅ Patent 10,287,585 granted on 2019-05-14Therapy
Also check out LINNANE PHARMA AB's (Malmo, Sweden) applicant profile with 6 patent applications submitted.
158416 ⎘